Madrigal Pharmaceuticals Statistics
Total Valuation
MDGL has a market cap or net worth of $9.88 billion. The enterprise value is $9.20 billion.
Important Dates
The next estimated earnings date is Thursday, October 30, 2025, before market open.
Earnings Date | Oct 30, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
MDGL has 22.29 million shares outstanding. The number of shares has increased by 10.46% in one year.
Current Share Class | 22.29M |
Shares Outstanding | 22.29M |
Shares Change (YoY) | +10.46% |
Shares Change (QoQ) | +0.52% |
Owned by Insiders (%) | 11.47% |
Owned by Institutions (%) | 70.71% |
Float | 10.98M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 18.91 |
Forward PS | 8.23 |
PB Ratio | 14.15 |
P/TBV Ratio | 14.28 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 17.85 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.11, with a Debt / Equity ratio of 0.18.
Current Ratio | 5.11 |
Quick Ratio | 4.46 |
Debt / Equity | 0.18 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -22.55 |
Financial Efficiency
Return on equity (ROE) is -36.30% and return on invested capital (ROIC) is -21.57%.
Return on Equity (ROE) | -36.30% |
Return on Assets (ROA) | -18.31% |
Return on Invested Capital (ROIC) | -21.57% |
Return on Capital Employed (ROCE) | -37.83% |
Revenue Per Employee | $976,415 |
Profits Per Employee | -$533,900 |
Employee Count | 528 |
Asset Turnover | 0.49 |
Inventory Turnover | 0.54 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +108.59% in the last 52 weeks. The beta is -1.02, so MDGL's price volatility has been lower than the market average.
Beta (5Y) | -1.02 |
52-Week Price Change | +108.59% |
50-Day Moving Average | 386.90 |
200-Day Moving Average | 331.07 |
Relative Strength Index (RSI) | 60.80 |
Average Volume (20 Days) | 330,222 |
Short Selling Information
The latest short interest is 4.14 million, so 18.56% of the outstanding shares have been sold short.
Short Interest | 4.14M |
Short Previous Month | 4.05M |
Short % of Shares Out | 18.56% |
Short % of Float | 37.70% |
Short Ratio (days to cover) | 10.95 |
Income Statement
In the last 12 months, MDGL had revenue of $515.55 million and -$281.90 million in losses. Loss per share was -$12.82.
Revenue | 515.55M |
Gross Profit | 496.37M |
Operating Income | -309.81M |
Pretax Income | -281.90M |
Net Income | -281.90M |
EBITDA | -308.40M |
EBIT | -309.81M |
Loss Per Share | -$12.82 |
Full Income Statement Balance Sheet
The company has $797.02 million in cash and $123.95 million in debt, giving a net cash position of $673.08 million or $30.20 per share.
Cash & Cash Equivalents | 797.02M |
Total Debt | 123.95M |
Net Cash | 673.08M |
Net Cash Per Share | $30.20 |
Equity (Book Value) | 695.98M |
Book Value Per Share | 31.32 |
Working Capital | 806.85M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$307.41 million and capital expenditures -$974,000, giving a free cash flow of -$308.39 million.
Operating Cash Flow | -307.41M |
Capital Expenditures | -974,000 |
Free Cash Flow | -308.39M |
FCF Per Share | -$13.84 |
Full Cash Flow Statement Margins
Gross margin is 96.28%, with operating and profit margins of -60.09% and -54.68%.
Gross Margin | 96.28% |
Operating Margin | -60.09% |
Pretax Margin | -54.68% |
Profit Margin | -54.68% |
EBITDA Margin | -59.82% |
EBIT Margin | -60.09% |
FCF Margin | n/a |
Dividends & Yields
MDGL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -10.46% |
Shareholder Yield | -10.46% |
Earnings Yield | -2.85% |
FCF Yield | -3.12% |
Dividend Details Analyst Forecast
The average price target for MDGL is $485.78, which is 9.63% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $485.78 |
Price Target Difference | 9.63% |
Analyst Consensus | Strong Buy |
Analyst Count | 10 |
Revenue Growth Forecast (5Y) | 84.06% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
MDGL has an Altman Z-Score of 9.73 and a Piotroski F-Score of 2.
Altman Z-Score | 9.73 |
Piotroski F-Score | 2 |